![Molecules | Free Full-Text | Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review | HTML Molecules | Free Full-Text | Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review | HTML](https://www.mdpi.com/molecules/molecules-25-04624/article_deploy/html/images/molecules-25-04624-g009.png)
Molecules | Free Full-Text | Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review | HTML
![Ultrasound controlled paclitaxel releasing system—A novel method for improving the availability of coronary artery drug coated balloon - Song - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library Ultrasound controlled paclitaxel releasing system—A novel method for improving the availability of coronary artery drug coated balloon - Song - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9a28dbcd-7964-4608-8262-525d17060e04/ccd28564-fig-0001-m.jpg)
Ultrasound controlled paclitaxel releasing system—A novel method for improving the availability of coronary artery drug coated balloon - Song - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library
![C. R. Bard Receives FDA Premarket Approval For The LUTONIX 035 Drug Coated Balloon - Medical Design and Outsourcing C. R. Bard Receives FDA Premarket Approval For The LUTONIX 035 Drug Coated Balloon - Medical Design and Outsourcing](https://media-ecn.s3.amazonaws.com/embedded_image/2017/08/LUTONIX%20035%20DCB%20PTA%20Catheter.jpg)
C. R. Bard Receives FDA Premarket Approval For The LUTONIX 035 Drug Coated Balloon - Medical Design and Outsourcing
![Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials - eClinicalMedicine Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ff42f8d7-c6b2-4796-b4be-a2ec53736535/gr1_lrg.jpg)
Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials - eClinicalMedicine
![New, Longer 220 mm Length of Lutonix 035 Drug-Coated Balloon Reduces Cost at Arkansas Heart Hospital New, Longer 220 mm Length of Lutonix 035 Drug-Coated Balloon Reduces Cost at Arkansas Heart Hospital](https://s3.amazonaws.com/HMP/hmp_ln/imported/2%20Cawich%20headshot.png)
New, Longer 220 mm Length of Lutonix 035 Drug-Coated Balloon Reduces Cost at Arkansas Heart Hospital
![New, Longer 220 mm Length of Lutonix 035 Drug-Coated Balloon Reduces Cost at Arkansas Heart Hospital New, Longer 220 mm Length of Lutonix 035 Drug-Coated Balloon Reduces Cost at Arkansas Heart Hospital](https://s3.amazonaws.com/HMP/hmp_ln/imported/2%20Cawich%20Fig%201-2.png)
New, Longer 220 mm Length of Lutonix 035 Drug-Coated Balloon Reduces Cost at Arkansas Heart Hospital
![Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions | Circulation: Cardiovascular Interventions Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/83f56475-26bd-4118-98bc-954d0e33cff3/e007702fig05.jpg)
Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions | Circulation: Cardiovascular Interventions
![Head-to-Head Trial Compares Low- to Higher-Dose Drug-Coated Balloons at a Critical Time - Endovascular Today Head-to-Head Trial Compares Low- to Higher-Dose Drug-Coated Balloons at a Critical Time - Endovascular Today](https://core4-cms.imgix.net/fig-1_1582900555.png)
Head-to-Head Trial Compares Low- to Higher-Dose Drug-Coated Balloons at a Critical Time - Endovascular Today
![New BARD LUTONIX 035 LX35130560 DRUG COATED PTA CATHETER 5.0MM x 60MM (X) Catheters For Sale - DOTmed Listing #2388401: New BARD LUTONIX 035 LX35130560 DRUG COATED PTA CATHETER 5.0MM x 60MM (X) Catheters For Sale - DOTmed Listing #2388401:](https://www.dotmed.com/images/listingpics2/2/3/8/8/2388401_2.jpg)
New BARD LUTONIX 035 LX35130560 DRUG COATED PTA CATHETER 5.0MM x 60MM (X) Catheters For Sale - DOTmed Listing #2388401:
![New BARD LUTONIX 035 LX35130560 DRUG COATED PTA CATHETER 5.0MM x 60MM (X) Catheters For Sale - DOTmed Listing #2388401: New BARD LUTONIX 035 LX35130560 DRUG COATED PTA CATHETER 5.0MM x 60MM (X) Catheters For Sale - DOTmed Listing #2388401:](https://images.dotmed.com/cgi-bin/size.pl?i=2388401.jpg&s=640&t=2)
New BARD LUTONIX 035 LX35130560 DRUG COATED PTA CATHETER 5.0MM x 60MM (X) Catheters For Sale - DOTmed Listing #2388401:
![An Experimental Study of Paclitaxel Embolisation During Drug Coated Balloon Angioplasty - European Journal of Vascular and Endovascular Surgery An Experimental Study of Paclitaxel Embolisation During Drug Coated Balloon Angioplasty - European Journal of Vascular and Endovascular Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0708c3c2-5032-4537-ab51-284044288314/gr1.jpg)